Intervacc is trading at €0.09, up 11.11% today, with no fresh company-specific news or sector headlines clearly tied to the move.
- The gain appears to be a low-liquidity, stock-specific move rather than a reaction to earnings, regulatory events, or broader market dynamics.
- There have been no recent announcements from the biotech firm, which specializes in animal health.
- The price action stands out as an isolated move in the absence of fundamental drivers or sector-wide catalysts.